- Report
- October 2025
- 487 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- March 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,155GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1774EUR$2,000USD£1,540GBP
- Report
- August 2025
- 150 Pages
Global
From €2528EUR$2,850USD£2,195GBP
€3415EUR$3,850USD£2,965GBP
- Report
- July 2025
- 350 Pages
Global
From €4390EUR$4,949USD£3,812GBP
- Report
- June 2025
- 400 Pages
Global
From €4390EUR$4,949USD£3,812GBP
- Report
- April 2025
- 192 Pages
Global
From €4431EUR$4,995USD£3,847GBP
- Report
- July 2025
- 120 Pages
Global
From €5278EUR$5,950USD£4,582GBP
- Report
- October 2025
- 563 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2474EUR$2,789USD£2,148GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2474EUR$2,789USD£2,148GBP
- Report
- July 2025
- 175 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- July 2024
- 150 Pages
Global
From €5278EUR$5,950USD£4,582GBP
- Report
- May 2023
- 260 Pages
Global
From €2351EUR$2,650USD£2,041GBP
- Report
- June 2024
- 200 Pages
Global
From €7052EUR$7,950USD£6,123GBP
- Report
- June 2024
- 200 Pages
Global
From €7052EUR$7,950USD£6,123GBP
- Report
- January 2022
- 60 Pages
Global
From €3504EUR$3,950USD£3,042GBP
- Report
- May 2024
- 137 Pages
Global
From €5765EUR$6,499USD£5,005GBP
- Report
- May 2024
- 135 Pages
Global
From €5765EUR$6,499USD£5,005GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more